Select M&As involving U.S. and European biotech companies 2023

Published by
Matej Mikulic,
Nov 9, 2024

In 2023, U.S. company Pfizer acquired U.S. company Seagen with a potential value of 43 billion U.S. dollars. This statistic shows the total potential value of select mergers and acquisitions involving U.S. and/or European biotechnology companies.

Selected European and U.S. biotechnology mergers and acquisitions by total potential value in 2023 (in billion euros)

Loading statistic...

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Use Ask Statista Research Service

Release date

June 2024

Region

Europe, Japan, United States

Survey time period

2023

Supplementary notes

Total potential value includes up-front, milestone and other payments from publicly available sources.

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Register now
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Biotechnology industry in Europe "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Biotechnology industry in Europe

Overview

4

Research and Development

4

Financing and M&As

7

Patents

4

Countries

5

Further related statistics

16

Further Content: You might find this interesting as well

Statistics

Topics

Biotechnology in EuropeBiotech drugsPharmaceutical industry in the U.S.Top pharmaceutical drugsBiotechnology industry in Germany
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Register now
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.